Osteoarthritis Drugs Market, Global Outlook and Forecast 2022-2028

February 2022 | 78 pages | ID: O22497B2BDD7EN
Market Monitor Global

Abstracts

Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.

This report contains market size and forecasts of Osteoarthritis Drugs in global, including the following market information:

Global Osteoarthritis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Osteoarthritis Drugs Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Osteoarthritis Drugs companies in 2021 (%)

The global Osteoarthritis Drugs market was valued at 5636 million in 2021 and is projected to reach US$ 7570.9 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Osteoarthritis Drugs include Johnson & Johnson, Pfizer, Eli Lilly, Abbott, GlaxoSmithKline, Sanofi and Flexion Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Osteoarthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Osteoarthritis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Osteoarthritis Drugs Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection
• External

Global Osteoarthritis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Osteoarthritis Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Osteoarthritis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Osteoarthritis Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Osteoarthritis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Osteoarthritis Drugs revenues share in global market, 2021 (%)

Key companies Osteoarthritis Drugs sales in global market, 2017-2022 (Estimated), (MT)

Key companies Osteoarthritis Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Pfizer
• Eli Lilly
• Abbott
• GlaxoSmithKline
• Sanofi
• Flexion Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Osteoarthritis Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Osteoarthritis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OSTEOARTHRITIS DRUGS OVERALL MARKET SIZE

2.1 Global Osteoarthritis Drugs Market Size: 2021 VS 2028
2.2 Global Osteoarthritis Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Osteoarthritis Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Osteoarthritis Drugs Players in Global Market
3.2 Top Global Osteoarthritis Drugs Companies Ranked by Revenue
3.3 Global Osteoarthritis Drugs Revenue by Companies
3.4 Global Osteoarthritis Drugs Sales by Companies
3.5 Global Osteoarthritis Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Osteoarthritis Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Osteoarthritis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Osteoarthritis Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Osteoarthritis Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Osteoarthritis Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Osteoarthritis Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
  4.1.4 External
4.2 By Type - Global Osteoarthritis Drugs Revenue & Forecasts
  4.2.1 By Type - Global Osteoarthritis Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Osteoarthritis Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Osteoarthritis Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Osteoarthritis Drugs Sales & Forecasts
  4.3.1 By Type - Global Osteoarthritis Drugs Sales, 2017-2022
  4.3.2 By Type - Global Osteoarthritis Drugs Sales, 2023-2028
  4.3.3 By Type - Global Osteoarthritis Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Osteoarthritis Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Osteoarthritis Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Osteoarthritis Drugs Revenue & Forecasts
  5.2.1 By Application - Global Osteoarthritis Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Osteoarthritis Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Osteoarthritis Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Osteoarthritis Drugs Sales & Forecasts
  5.3.1 By Application - Global Osteoarthritis Drugs Sales, 2017-2022
  5.3.2 By Application - Global Osteoarthritis Drugs Sales, 2023-2028
  5.3.3 By Application - Global Osteoarthritis Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Osteoarthritis Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Osteoarthritis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Osteoarthritis Drugs Revenue & Forecasts
  6.2.1 By Region - Global Osteoarthritis Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Osteoarthritis Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Osteoarthritis Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Osteoarthritis Drugs Sales & Forecasts
  6.3.1 By Region - Global Osteoarthritis Drugs Sales, 2017-2022
  6.3.2 By Region - Global Osteoarthritis Drugs Sales, 2023-2028
  6.3.3 By Region - Global Osteoarthritis Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Osteoarthritis Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Osteoarthritis Drugs Sales, 2017-2028
  6.4.3 US Osteoarthritis Drugs Market Size, 2017-2028
  6.4.4 Canada Osteoarthritis Drugs Market Size, 2017-2028
  6.4.5 Mexico Osteoarthritis Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Osteoarthritis Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Osteoarthritis Drugs Sales, 2017-2028
  6.5.3 Germany Osteoarthritis Drugs Market Size, 2017-2028
  6.5.4 France Osteoarthritis Drugs Market Size, 2017-2028
  6.5.5 U.K. Osteoarthritis Drugs Market Size, 2017-2028
  6.5.6 Italy Osteoarthritis Drugs Market Size, 2017-2028
  6.5.7 Russia Osteoarthritis Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Osteoarthritis Drugs Market Size, 2017-2028
  6.5.9 Benelux Osteoarthritis Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Osteoarthritis Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Osteoarthritis Drugs Sales, 2017-2028
  6.6.3 China Osteoarthritis Drugs Market Size, 2017-2028
  6.6.4 Japan Osteoarthritis Drugs Market Size, 2017-2028
  6.6.5 South Korea Osteoarthritis Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Osteoarthritis Drugs Market Size, 2017-2028
  6.6.7 India Osteoarthritis Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Osteoarthritis Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Osteoarthritis Drugs Sales, 2017-2028
  6.7.3 Brazil Osteoarthritis Drugs Market Size, 2017-2028
  6.7.4 Argentina Osteoarthritis Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Osteoarthritis Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Osteoarthritis Drugs Sales, 2017-2028
  6.8.3 Turkey Osteoarthritis Drugs Market Size, 2017-2028
  6.8.4 Israel Osteoarthritis Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Osteoarthritis Drugs Market Size, 2017-2028
  6.8.6 UAE Osteoarthritis Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Osteoarthritis Drugs Major Product Offerings
  7.1.4 Johnson & Johnson Osteoarthritis Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Osteoarthritis Drugs Major Product Offerings
  7.2.4 Pfizer Osteoarthritis Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Pfizer Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Osteoarthritis Drugs Major Product Offerings
  7.3.4 Eli Lilly Osteoarthritis Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott Osteoarthritis Drugs Major Product Offerings
  7.4.4 Abbott Osteoarthritis Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Abbott Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Osteoarthritis Drugs Major Product Offerings
  7.5.4 GlaxoSmithKline Osteoarthritis Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Osteoarthritis Drugs Major Product Offerings
  7.6.4 Sanofi Osteoarthritis Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Sanofi Key News
7.7 Flexion Therapeutics
  7.7.1 Flexion Therapeutics Corporate Summary
  7.7.2 Flexion Therapeutics Business Overview
  7.7.3 Flexion Therapeutics Osteoarthritis Drugs Major Product Offerings
  7.7.4 Flexion Therapeutics Osteoarthritis Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Flexion Therapeutics Key News

8 GLOBAL OSTEOARTHRITIS DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Osteoarthritis Drugs Production Capacity, 2017-2028
8.2 Osteoarthritis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Osteoarthritis Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 OSTEOARTHRITIS DRUGS SUPPLY CHAIN ANALYSIS

10.1 Osteoarthritis Drugs Industry Value Chain
10.2 Osteoarthritis Drugs Upstream Market
10.3 Osteoarthritis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Osteoarthritis Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Osteoarthritis Drugs in Global Market
Table 2. Top Osteoarthritis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Osteoarthritis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Osteoarthritis Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Osteoarthritis Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Osteoarthritis Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Osteoarthritis Drugs Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Osteoarthritis Drugs Product Type
Table 9. List of Global Tier 1 Osteoarthritis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Osteoarthritis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Osteoarthritis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Osteoarthritis Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Osteoarthritis Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Osteoarthritis Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Osteoarthritis Drugs Sales (MT), 2023-2028
Table 16. By Application – Global Osteoarthritis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Osteoarthritis Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Osteoarthritis Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Osteoarthritis Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Osteoarthritis Drugs Sales (MT), 2023-2028
Table 21. By Region – Global Osteoarthritis Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Osteoarthritis Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Osteoarthritis Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Osteoarthritis Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Osteoarthritis Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Osteoarthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Osteoarthritis Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Osteoarthritis Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Osteoarthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Osteoarthritis Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Osteoarthritis Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Osteoarthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Osteoarthritis Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Osteoarthritis Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Osteoarthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Osteoarthritis Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Osteoarthritis Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Osteoarthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Osteoarthritis Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Osteoarthritis Drugs Sales, (MT), 2023-2028
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Osteoarthritis Drugs Product Offerings
Table 48. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Osteoarthritis Drugs Product Offerings
Table 51. Pfizer Osteoarthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Eli Lilly Corporate Summary
Table 53. Eli Lilly Osteoarthritis Drugs Product Offerings
Table 54. Eli Lilly Osteoarthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Abbott Corporate Summary
Table 56. Abbott Osteoarthritis Drugs Product Offerings
Table 57. Abbott Osteoarthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. GlaxoSmithKline Corporate Summary
Table 59. GlaxoSmithKline Osteoarthritis Drugs Product Offerings
Table 60. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Sanofi Corporate Summary
Table 62. Sanofi Osteoarthritis Drugs Product Offerings
Table 63. Sanofi Osteoarthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Flexion Therapeutics Corporate Summary
Table 65. Flexion Therapeutics Osteoarthritis Drugs Product Offerings
Table 66. Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Osteoarthritis Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 68. Global Osteoarthritis Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Osteoarthritis Drugs Production by Region, 2017-2022 (MT)
Table 70. Global Osteoarthritis Drugs Production by Region, 2023-2028 (MT)
Table 71. Osteoarthritis Drugs Market Opportunities & Trends in Global Market
Table 72. Osteoarthritis Drugs Market Drivers in Global Market
Table 73. Osteoarthritis Drugs Market Restraints in Global Market
Table 74. Osteoarthritis Drugs Raw Materials
Table 75. Osteoarthritis Drugs Raw Materials Suppliers in Global Market
Table 76. Typical Osteoarthritis Drugs Downstream
Table 77. Osteoarthritis Drugs Downstream Clients in Global Market
Table 78. Osteoarthritis Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Osteoarthritis Drugs Segment by Type
Figure 2. Osteoarthritis Drugs Segment by Application
Figure 3. Global Osteoarthritis Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Osteoarthritis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Osteoarthritis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Osteoarthritis Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Osteoarthritis Drugs Revenue in 2021
Figure 9. By Type - Global Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Osteoarthritis Drugs Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Osteoarthritis Drugs Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 19. US Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 24. Germany Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 33. China Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Osteoarthritis Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Osteoarthritis Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Osteoarthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Osteoarthritis Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Osteoarthritis Drugs by Region, 2021 VS 2028
Figure 50. Osteoarthritis Drugs Industry Value Chain
Figure 51. Marketing Channels